Managing adverse events associated with cellular therapies
Agenda
Myeloma Connect 2022 is a series of live, interactive broadcasts, each focussed on a specific topic relevant to hematologists treating patients with multiple myeloma. The series will focus on key issues relating to the management of patients with multiple myeloma.
Learning objective:
After participating in this webinar, viewers should be able to:
- Outline how to manage adverse events associated with cellular therapies in patients with multiple myeloma
Faculty:
- Michel Delforge (Belgium)
- María Victoria Mateos (Spain)
More Info
47 Minutes
EM-56870 - Date of preparation: December 2021